Forbes featured our scientific discoveries of the efficacy of SIM01 in treating Long Covid
Christmas Eve Exciting News!🎉🎉
Thrilled to share that #Forbes has just featured our #scientific_discoveries of the efficacy of #SIM01 in treating #Long_Covid 🔬👨⚕⚕👩⚕⚕ which recently published in Lancet Infectious Diseases.
As we continue the expansion of SIM01 outside of Asia🌏, we are delighted to announce new potential partnerships with several research institutions in the USA and Europe. Stay tuned on our more updates and milestones in 2024! 📢 📢
Forbes article: https://www-forbes-com.cdn.ampproject.org/c/s/www.forbes.com/sites/davewessner/2023/12/21/new-research-links-long-covid-and-the-microbiome-probiotics-may-be-an-answer/amp/
Published Clinical Paper in Lancet Infectious Diseases: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00685-0/fulltext
